Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abhijit Pal

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Pathology|June 25, 2024
The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinomaJing Jing Li, Xiao Juan Wu, Mahtab Farzin, et al.
Cancer Treatment and Research Communications|February 7, 2021
Research Related Tumour Biopsies in Early-Phase Trials with Simultaneous Molecular Characterisation - a Single Unit ExperienceAndrea Biondo, Abhijit Pal, Ruth Riisnaes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 30, 2023
Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma-RIOMesoNicholas McNamee, Catriona Harvey, Lauren Gray, et al.
JTO Clinical and Research Reports|September 30, 2021
Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian PopulationTamkin Ahmadzada, Wendy A Cooper, Mikaela Holmes, et al.
Asia-Pacific Journal of Clinical Oncology|February 6, 2025
Smoking Cessation Practices in Australian Oncology Settings: A Cross-Sectional Study of Who, How, and WhenAlison Luk Young, Melissa McEnallay, Fiona Day, et al.
Asia-Pacific Journal of Clinical Oncology|February 1, 2025
A Comparison of Australian Oncology Clinicians' Smoking Cessation Care Practices for People Who Currently Smoke Versus Those Who Report Recently Stopping SmokingAlison Luk Young, Melissa McEnallay, Fiona Day, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2025
Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutationsAdel Shahnam, Alexander Davis, Lauren Julia Brown, et al.
Journal for Immunotherapy of Cancer|June 18, 2022
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumorsDionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal, et al.
Trials|June 12, 2026
Healthcare professionals' perspectives on the barriers and enablers of cancer clinical trial participation among Arabic-speaking cancer patients in Australia: a qualitative studyRayan Saleh Moussa, Layla M Edwards, Michael Camit, et al.
Cancer Discovery|January 12, 2021
Targeting the p300/CBP Axis in Lethal Prostate CancerJonathan Welti, Adam Sharp, Nigel Brooks, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Pathology|June 25, 2024
The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinomaJing Jing Li, Xiao Juan Wu, Mahtab Farzin, et al.
Cancer Treatment and Research Communications|February 7, 2021
Research Related Tumour Biopsies in Early-Phase Trials with Simultaneous Molecular Characterisation - a Single Unit ExperienceAndrea Biondo, Abhijit Pal, Ruth Riisnaes, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 30, 2023
Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma-RIOMesoNicholas McNamee, Catriona Harvey, Lauren Gray, et al.
JTO Clinical and Research Reports|September 30, 2021
Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian PopulationTamkin Ahmadzada, Wendy A Cooper, Mikaela Holmes, et al.
Asia-Pacific Journal of Clinical Oncology|February 6, 2025
Smoking Cessation Practices in Australian Oncology Settings: A Cross-Sectional Study of Who, How, and WhenAlison Luk Young, Melissa McEnallay, Fiona Day, et al.
Asia-Pacific Journal of Clinical Oncology|February 1, 2025
A Comparison of Australian Oncology Clinicians' Smoking Cessation Care Practices for People Who Currently Smoke Versus Those Who Report Recently Stopping SmokingAlison Luk Young, Melissa McEnallay, Fiona Day, et al.
Lung Cancer (Amsterdam, Netherlands)|February 20, 2025
Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutationsAdel Shahnam, Alexander Davis, Lauren Julia Brown, et al.
Journal for Immunotherapy of Cancer|June 18, 2022
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumorsDionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal, et al.
Trials|June 12, 2026
Healthcare professionals' perspectives on the barriers and enablers of cancer clinical trial participation among Arabic-speaking cancer patients in Australia: a qualitative studyRayan Saleh Moussa, Layla M Edwards, Michael Camit, et al.
Cancer Discovery|January 12, 2021
Targeting the p300/CBP Axis in Lethal Prostate CancerJonathan Welti, Adam Sharp, Nigel Brooks, et al.
Pageof 5